Pharmacologic advances in the global control and treatment of malaria: Combination therapy and resistance

Clinical Pharmacology and Therapeutics

Volumn 82, Issue 5, 2007, Pages 601-605

  Nyunt, M M ^a   Plowe, C V ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Maryland School of Medicine Center for Vaccine Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMETHER; ARTEMISININ; ARTEMISININ DERIVATIVE; ARTESUNATE; BENFLUMETOL; CHLOROQUINE; CHLORPROGUANIL PLUS DAPSONE; CYCLOGUANIL; FANSIDAR; MEFLOQUINE; PIPERAQUINE; PYRIMETHAMINE; QUININE;

ANEMIA; AREA UNDER THE CURVE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; GEOGRAPHIC DISTRIBUTION; HUMAN; MALARIA; MALARIA CONTROL; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; PLASMODIUM FALCIPARUM; PREGNANCY; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; TREATMENT INDICATION; WORLD HEALTH ORGANIZATION;

AMODIAQUINE; ANTIMALARIALS; ARTEMISININS; CHLOROGUANIDE; CHLOROQUINE; DAPSONE; DRUG DESIGN; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FEMALE; FLUORENES; HALF-LIFE; HUMANS; MALARIA; MEFLOQUINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PYRIMETHAMINE; QUININE; SESQUITERPENES; SULFADOXINE; WORLD HEALTH;

EID: 35448959339     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/sj.clpt.6100361     Document Type: Review

References (30)

1. Trape, J.F. The public health impact of chloroquine resistance in Africa. Am. J. Trop. Med. Hyg. 64, 12-17 (2001).
2. ter Kuile, F.O., van Eijk, A.M. & Filler, S.J. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. JAMA 297, 2603-2616 (2007).
3. Covell, G., Coatney, G.R., Field, J.W. & Singh, J. Chemotherapy of malaria. Monogr. Ser. World Health Organ. 27, 1-123 (1955).
4. Peters, W. Chemotherapy and Drug Resistance in Malaria (Academic, London, 1970).
5. White, N.J. & Olliaro, P.L. Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria. Parasitol. Today 12, 399-401 (1996).
6. White, N.J. et al. Averting a malaria disaster. Lancet 353, 1965-1967 (1999).
7. Watkins, W.M. et al. Chlorproguanil/dapsone for the treatment of non-severe Plasmodium falciparum malaria in Kenya: a pilot study. Trans. R. Soc. Trop. Med. Hyg. 82, 398-403 (1988).
8. Sulo, J. et al. Chlorproguanil-dapsone versus sulfadoxine- pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial. Lancet 360, 1136-1143 (2002).
9. Hien, T.T. & White, N.J. Qinghaosu. Lancet 341, 603-608 (1993).
10. White, N.J. Combination treatment for falciparum prophylaxis. Lancet 1, 680-681 (1987).
11. Nosten, F. et al. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 356, 297-302 (2000).
12. Hastings, I.M., Watkins, W.M. & White, N.J. The evolution of drug-resistant malaria: the role of drug elimination half-life. Philos. Trans. R. Soc. Lond. B Biol. Sci. 357, 505-519 (2002).
13. Denis, M.B. et al. Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia. Trop. Med. Int. Health 11, 1360-1366 (2006).
14. Vijaykadga, S. et al. In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. Trop. Med. Int. Health 11, 211-219 (2006).
15. Hastings, I.M. & Watkins, W.M. Tolerance is the key to understanding antimalarial drug resistance. Trends Parasitol. 22, 71-77 (2006).
16. Watkins, W.M. & Mosobo, M. Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life. Trans. R. Soc. Trop. Med. Hyg. 87, 75-78 (1993).
17. Hastings, I.M. & Ward, S.A. Coartem (artemether-lumefantrine) in Africa: the beginning of the end? J. Infect. Dis. 192, 1303-1304 (2005).
18. Plowe, C.V., Kublin, J.G. & Doumbo, O.K. P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates. Drug Resist. Updat. 1, 389-396 (1998).
19. Laufer, M.K. et al. Return of chloroquine antimalarial efficacy in Malawi. N. Engl. J. Med. 355, 1959-1966 (2006).
20. Laufer, M.K., Djimde, A.A. & Plowe, C.V. Monitoring and deterring drug resistant malaria in the era of combination therapy. Am. J. Trop. Med. Hyg. (in press).
21. Kamya, M.R. et al. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial. PLoS Clin. Trials 2, e20 (2007).
22. Hasugian, A.R. et al. Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and post treatment prophylaxis against multi-drug resistant P. falciparum and P. vivax. Clin. Infect. Dis. 44, 1067-1074 (2007).
23. Ward, S.A. et al. Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance. Lancet Infect. Dis. 7, 136-144 (2007).
24. Posner, G.H. et al. Malaria-infected mice are cured by a single dose of novel artemisinin derivatives. J. Med. Chem. 50, 2516-2519 (2007).
25. Ridley, R.G. & Hudson, A.T. Chemotherapy of malaria. Curr. Opin. Infect. Dis. 11, 691-705 (1998).
26. Rosenthal, P.J. Antimalarial drug discovery: old and new approaches. J. Exp. Biol. 206, 3735-3744 (2003).
27. Brady, R.L. & Cameron, A. Structure-based approaches to the development of novel anti-malarials. Curr. Drug Targets 5, 137-149 (2004).
28. Moen, M.D. & Plosker, G.L. Zolpidem extended-release. CNS Drugs 20, 419-426 (2006).
29. Contacos, P.G., Coatney, G.R., Lunn, J.S. & Chin, W. The urinary excretion and the antimalarial activity of CI-501 (cycloguanil-pamoate, Camolar) against vivax and falciparum malaria. Am. J. Trop. Med. Hyg. 15, 281-286 (1966).
30. Gabriels, M. & Plaizier-Vercammen, J. Physical and chemical evaluation of liposomes, containing artesunate. J. Pharm. Biomed. Anal. 31, 655-667 (2003).